Evidence map›Paper›PMID 42770468›Full record

Observational studyActa orthopaedica2026

Development of osteoarthritis in adults with untreated hip dysplasia: a longitudinal observational study.

Rebecka Vinge, Cecilia Rogmark, Daniel Wenger, Søren Overgaard, Carl Johan Tiderius

Abstract readObservational Study
In one paragraph

Observational study in Acta orthopaedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rebecka VingeOrthopaedics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Orthopaedics, Skåne University Hospital, Lund and Malmö, Sweden. Rebecka.vinge@med.lu.se.
Cecilia RogmarkOrthopaedics, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Department of Orthopaedics, Skåne University Hospital, Lund and Malmö, Sweden.ORCID 0000-0002-6556-4320
Daniel WengerOrthopaedics, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Department of Orthopaedics, Skåne University Hospital, Lund and Malmö, Sweden.ORCID 0000-0002-8194-2432
Søren OvergaardOrthopaedic Surgery, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Orthopaedic Surgery and Traumatology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.ORCID 0000-0001-6829-4787
Carl Johan TideriusOrthopaedics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Orthopaedics, Skåne University Hospital, Lund and Malmö, Sweden.ORCID 0000-0001-7717-1578

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeAlthough hip dysplasia is a risk factor for osteoarthritis (OA), its natural progression in adults remains poorly understood. In a longitudinal observational study, we aimed to estimate differences in OA incidence, time to OA, and minimum joint space width (JSW) between dysplastic hips and contralateral non-dysplastic hips.

methodsAdults aged 20-70 years who underwent pelvic radiographs in Malmö, Sweden, during 2007-2008 were included. Inclusion criteria were unilateral hip dysplasia (lateral center edge angle ≤ 20°), no OA at baseline, and available follow-up imaging of both hips. OA incidence was assessed using last available follow-up imaging, whereas minimum JSW was measured bilaterally on the last available radiograph of native hips.

results50 participants (median age 47 years, IQR 39-62, 36 women) were included, with median follow-up 12.5 years (IQR 7.8-14.7). OA developed in 19/50 dysplastic hips and 16/50 non-dysplastic hips, corresponding to a paired risk difference of 6 percentage points (95% confidence interval [CI] -7 to 20). Mean time to OA was 8.2 years (SD 5.2) for dysplastic hips and 9.6 years (SD 5.1) for non-dysplastic hips (mean difference -1.2 years, CI -4.8 to 2.4). Minimum JSW at follow-up was 3.3 mm (SD 1.3) in dysplastic hips and 3.5 mm (SD 0.9) in non-dysplastic hips (mean difference -0.2 mm, CI - 0.6 to 0.2).

conclusionNo clear differences were observed in OA incidence, time to OA, or minimum JSW between dysplastic and contralateral non-dysplastic hips.

Indexed as

Hip DislocationOsteoarthritis, HipAdultAgedDisease ProgressionFemaleHip JointHumansIncidenceLongitudinal StudiesMaleMiddle AgedRadiographyRisk FactorsSwedenYoung Adult

Identifiers

PMID42770468
PMCPMC13595187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.